The only one he tested was CCL5 (RANTES) and leronlimab

New Post Public Reply Private Reply Replies (1) Message Board
MGK_2 ohm20 #124859
863

Quote:
The only one he tested was CCL5 (RANTES) and leronlimab blocked that.


Therefore to the CCR5 receptor, LL competitively out binds RANTES & HIV.

And when LL does out bind RANTES, then what happens? The immune system goes to work as it should. Inflammation goes down because Disease goes away and healing begins. The immune system, when operating properly, eradicates disease and restores health. Therefore, the immune system reduces inflammation when it works properly. That is the overall end goal.

With higher CCR5 expression in the haplotype, 700mg LL did wonders both on PDFF as well as cT1. Why? Because LL allowed normal functionality of the immune system in and around the hepatocytes reducing lipogenesis, reducing cell apoptosis, and reducing the release of more chemokines to attract more cytokines which would have lead to more natural killer cells to the liver which would have led to an increase in scar tissue. All of that was reduced because LL restores proper immune functioning which restores proper hepatocyte functioning which reduces steatosis and scar tissue formation.

In Long Haulers, patients have zero immune system. All they have are an over worked, over burdened, fatigued immune system which do not eradicate spike proteins even if you put them smack dab infront of a Natural KIller Cell even if the spike protein was handed to it on a silver antigen presention platter.

No, it would shrug it off and leave it be! Why? CCL5 clogged up all the CCR5 receptors on the Tregs and caused all the Tregs to be active in REGULATING or SUPPRESSING the immune system in Long Haulers.

Why are the Tregs confused about what is self and what is foreign? Why can the T regs not recognize spike protein from self when they were trained in the thymus about exactly what is self and what is not self? Why Not? Because the T regs CCR5 receptors were fully bound by CCL5 RANTES and then internalized the CCR5 receptors thereby reducing their cell surface expression which was found in the Long Haulers trial. The mass quantity of RANTES made the T regs stupid traitors.

That means when ever there was a NKC or a Macrophage or a Dendrite cell presenting a spike protein asking the T reg if it should have the spike protein for dinner, the T reg says, "No, put that back; you are never to eat that"

Also, to add insult to injury, the Innate Immune system puts out the fuel for both the T regs and the Adaptive Arm, which is Interleukin 2. Without IL2, T regs are done and so is the adaptive arm. But there are lots of IL2 receptors on T regs. So when T regs are operating, they consume all the Interleukin 2 and the adaptive arm gets none. So the adaptive arm falls asleep by the wayside. The adaptive arm has no energy, no will to live, no get up and go without Interleukin 2, which is exactly what the T regs want, a SUPPRESSED IMMUNE SYSTEM. This is Long Haulers.

Bring on Leronlimab. All the CCL5 RANTES are immediately dislodged from the CCR5 receptors on the Tregs. Tregs are immediately awakened from their trance. Immediately, aware of their recent zombie phase, now, no longer confounded by the harming effect of CCL5 RANTES. All of a sudden, the T regs can tell what is self from what is foreign. The T regs remove their REGULATORY / SUPPRESSIVE control on the NKCs, Dendrites and CD8 Cytotoxic Killer Cells causing the Adaptive Arm of the Immune system to immediately return back to attack mode destroy the spike protein leading to health. The Immune system returns back and does what it was designed to do.

Why does RANTES confound the T reg, where it attaches at the same N terminus on CCR5 as does LL as does HIV. If LL impeded cytokine signaling as you say it does, that is, to reduce inflammation, how then is healing achieved without communication? If it is just as much as an impediment to immunocommunication as RANTES, then how is it that the immune system is so efficient when LL binds to CCR5 if there, as you say, exists no cellular communication?

Surely we can say that it is effective because it is PREVENTING CCL5 RANTES from binding and even dislodges it from the N terminus when in sufficient quantity. But we can not definitively say that it blocks/hinders/obstructs other cellular chemokine pathways.

Wouldn't it make more sense to understand that CCL5 RANTES, confounds and blocks normal immunocommunicatory signals when it binds to CCR5 because of its confomational changes it induces to CCR5 when it binds to it.

Surely, it is exactly this effect that we are witnessing which RANTES achieves when it binds to CCR5, Mass delusion and trance like states, almost at a "Stalemate" in chess when no party can make a move, but it is this way because nobody involved knows what's going on when CCL5 binds there. Because intra-cellular interleukin communication ceases with RANTES bound to CCR5.

But, when LL displaces RANTES, and takes over that binding site, all immunoregulatory communication is immediately re-established and things start working as they should, only RANTES can not bind to CCR5 anymore. Chemokines are not blocked, CCR5 maintains its shape, when LL is bound to CCR5, the signals of all the interleukins are transmitted efficiently, thereby effecting a healing response which reduces inflammation which is the design of the immune system, to restore health.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jersey Teamsters Stand Firm for Fair Health Worker Deal

Updated Category News Views 117

ImageCare Workers Ready to Strike Normally, when we hear about health care, we're pretending it’s this well-oiled machine. But here we are, witnessing techs and aides at ImageCare gearing up to strike for the first time. Sussex County’s finest have had it up to their ears negotiating for a union contract that doesn’t treat them like an afterthought. Two-Year...

Continue Reading
Tech Job Market Surges with AI and IT Skills Spike

Updated Category News Views 92

Alright, folks, though we're not drowning in champagne just yet, there's a promising uptick in October's tech employment, signaling a rebound or at least some relief for tech pros and market watchers. CompTIA's numbers show a boost of 7,200 jobs in the tech industry while IT occupations expanded by 26,000 slots. That's no small feat when the general job scene elsewhere...

Continue Reading
CorelDRAW's Flexibility: A Designer's One-Time Buy?

Updated Category News Views 66

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

Continue Reading
Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 13

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
WIC 2026: Global Connectivity and Cyber Futures

Updated Category News Views 144

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Continue Reading
VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Updated Category News Views 86

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Continue Reading
Pre-Owned Jet Inventory Rises; Price Trends Unclear

Updated Category News Views 83

October's Pre-Owned Aircraft Inventory: A Mixed Bag Nothing like leafing through October's data on pre-owned jets and feeling your stomach do that weird flip-flop. Inventory's nudging up, but it's still on its knees compared to last year's numbers. According to Sandhills Global's fresh aviation market reports, we got an increase in what's available on platforms like...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 98

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
QORAI CORP's Q4 Nexus: A New AI Frontier

Updated Category News Views 51

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Continue Reading
Sass Magazine's 2026 COZY Issue Embraces Intentional Joy

Updated Category News Views 70

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

Continue Reading

Top 5 Most Recently Viewed Articles

Crypto ETFs Make Waves: Dogecoin and XRP Soar in Trading

Updated Category News Views 209

Exciting Developments in Cryptocurrency ETFs In a remarkable turn of events for the cryptocurrency market, Dogecoin (DOGE) and XRP are experiencing a surge as they mark groundbreaking trading volumes on the launch day of their respective exchange-traded funds (ETFs). This uptick comes on the heels of the SEC's announcement regarding enhanced listing standards for...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 159

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Zoom Communications Exceeds Expectations with FY2025 Report

Updated Category News Views 933

Zoom's Impressive Year-End Financial Report Zoom Communications, Inc. (NASDAQ: ZM) recently published its financial results for the fourth quarter and the entirety of fiscal year 2025, reflecting substantial growth and innovation. With a total revenue of $1,184.1 million for the fourth quarter, this marks a year-over-year increase of 3.3%. When evaluated in constant...

Continue Reading
Investors Alert: Key Class Action Deadlines Upcoming

Updated Category News Views 230

Class Action Lawsuits Overview Investors, pay close attention! Class action lawsuits are now underway for several publicly-traded companies, and shareholder involvement is crucial. One such entity actively pursuing these cases is The Law Offices of Frank R. Cruz, reminding affected shareholders of their rights. Time is of the essence, as there are strict deadlines for...

Continue Reading
Fermi Inc. (FRMI) Faces Significant Setback with Tenant News

Updated Category News Views 182

Fermi Inc. Shares Decline Significantly Following Contract Issues On a recent day, investors of Fermi Inc. (NASDAQ: FRMI) experienced a notable drop in share prices, with a staggering decline of about 33%. This drop followed the announcement regarding the termination of an essential contract with a prospective anchor tenant, known as the First Tenant, for Fermi's...

Continue Reading